Bellinzona, Switzerland

Matteo Samuele Pizzuto

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matteo Samuele Pizzuto: Innovator in Antibody Research

Introduction

Matteo Samuele Pizzuto is a notable inventor based in Bellinzona, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies for therapeutic applications. His work focuses on creating solutions to combat infections, showcasing his dedication to advancing medical science.

Latest Patents

Matteo holds a patent for "Antibodies against species," which provides antibodies and antigen-binding fragments that are specific for certain infections. This patent outlines methods for neutralizing infections in subjects, emphasizing the potential of IgA antibodies, including secretory IgA antibodies. The patent also includes pharmaceutical compositions that utilize these antibodies and methods for treating or preventing infections, particularly through oral administration of recombinant secretory IgA antibodies.

Career Highlights

Throughout his career, Matteo has worked with prominent organizations such as Humabs Biomed SA and the Institute for Research in Biomedicine. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Matteo has collaborated with notable colleagues, including Fabio Benigni and Davide Corti. These partnerships have enhanced his research efforts and expanded the impact of his work in the biomedical community.

Conclusion

Matteo Samuele Pizzuto's innovative work in antibody research exemplifies his commitment to improving health outcomes through scientific advancements. His contributions are paving the way for new therapeutic approaches to combat infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…